RY BILLADEAU: Open Payments
NPI 1073145199 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 29 payments from 5 companies in 2025. Trend: 2023 $520 · 2024 $315 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $258 |
| Lundbeck LLC | 11 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $158 |
| E.R. Squibb & Sons, L.L.C. | 1 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
Products named: SPRAVATO, REXULTI, CAPLYTA, COBENFY, FANAPT.
Industry payments across NH — which companies pay providers there.
